Jasper Hellweg
Stock Analyst at Argus Research
(2.13)
# 2,920
Out of 5,031 analysts
88
Total ratings
48.61%
Success rate
4.1%
Average return
Main Sectors:
Stocks Rated by Jasper Hellweg
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZTS Zoetis | Reiterates: Buy | $190 | $144.06 | +31.89% | 7 | Sep 9, 2025 | |
| BIIB Biogen | Downgrades: Hold | n/a | $143.00 | - | 4 | Apr 4, 2025 | |
| UTHR United Therapeutics | Maintains: Buy | $360 → $400 | $433.34 | -7.69% | 7 | Oct 31, 2024 | |
| ILMN Illumina | Upgrades: Buy | $150 | $95.46 | +57.13% | 7 | Aug 28, 2024 | |
| SNY Sanofi | Maintains: Buy | $55 → $60 | $50.62 | +18.53% | 2 | Jul 26, 2024 | |
| REGN Regeneron Pharmaceuticals | Maintains: Buy | $1,060 → $1,170 | $578.05 | +102.40% | 9 | Jun 25, 2024 | |
| VRTX Vertex Pharmaceuticals | Maintains: Buy | $465 → $550 | $416.81 | +31.95% | 7 | Jun 17, 2024 | |
| AZN AstraZeneca | Maintains: Buy | $80 → $85 | $84.69 | +0.37% | 3 | May 30, 2024 | |
| NVO Novo Nordisk | Maintains: Buy | $115 → $125 | $54.37 | +129.91% | 1 | Feb 1, 2024 | |
| MRNA Moderna | Maintains: Buy | $160 → $140 | $26.01 | +438.25% | 4 | Sep 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $229.57 | - | 2 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $19.31 | - | 1 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $260 → $290 | $204.55 | +41.77% | 4 | Sep 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $100 | $104.83 | -4.61% | 3 | Jun 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $270 → $295 | $285.94 | +3.17% | 4 | May 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $9.16 | - | 3 | May 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $135 | $189.51 | -28.76% | 5 | Oct 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $23.09 | - | 2 | Sep 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $21.62 | - | 2 | Apr 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $226.91 | - | 3 | Apr 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $33.71 | - | 4 | Oct 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $155 | $426.16 | -63.63% | 3 | Nov 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $85 → $90 | $121.65 | -26.02% | 1 | Sep 19, 2018 |
Zoetis
Sep 9, 2025
Reiterates: Buy
Price Target: $190
Current: $144.06
Upside: +31.89%
Biogen
Apr 4, 2025
Downgrades: Hold
Price Target: n/a
Current: $143.00
Upside: -
United Therapeutics
Oct 31, 2024
Maintains: Buy
Price Target: $360 → $400
Current: $433.34
Upside: -7.69%
Illumina
Aug 28, 2024
Upgrades: Buy
Price Target: $150
Current: $95.46
Upside: +57.13%
Sanofi
Jul 26, 2024
Maintains: Buy
Price Target: $55 → $60
Current: $50.62
Upside: +18.53%
Regeneron Pharmaceuticals
Jun 25, 2024
Maintains: Buy
Price Target: $1,060 → $1,170
Current: $578.05
Upside: +102.40%
Vertex Pharmaceuticals
Jun 17, 2024
Maintains: Buy
Price Target: $465 → $550
Current: $416.81
Upside: +31.95%
AstraZeneca
May 30, 2024
Maintains: Buy
Price Target: $80 → $85
Current: $84.69
Upside: +0.37%
Novo Nordisk
Feb 1, 2024
Maintains: Buy
Price Target: $115 → $125
Current: $54.37
Upside: +129.91%
Moderna
Sep 13, 2023
Maintains: Buy
Price Target: $160 → $140
Current: $26.01
Upside: +438.25%
Apr 5, 2023
Downgrades: Hold
Price Target: n/a
Current: $229.57
Upside: -
Jan 27, 2022
Downgrades: Hold
Price Target: n/a
Current: $19.31
Upside: -
Sep 10, 2021
Maintains: Buy
Price Target: $260 → $290
Current: $204.55
Upside: +41.77%
Jun 9, 2021
Upgrades: Buy
Price Target: $100
Current: $104.83
Upside: -4.61%
May 20, 2021
Maintains: Buy
Price Target: $270 → $295
Current: $285.94
Upside: +3.17%
May 5, 2021
Downgrades: Hold
Price Target: n/a
Current: $9.16
Upside: -
Oct 21, 2020
Upgrades: Buy
Price Target: $135
Current: $189.51
Upside: -28.76%
Sep 4, 2020
Downgrades: Hold
Price Target: n/a
Current: $23.09
Upside: -
Apr 17, 2020
Downgrades: Hold
Price Target: n/a
Current: $21.62
Upside: -
Apr 6, 2020
Downgrades: Hold
Price Target: n/a
Current: $226.91
Upside: -
Oct 30, 2019
Downgrades: Hold
Price Target: n/a
Current: $33.71
Upside: -
Nov 6, 2018
Maintains: Buy
Price Target: $150 → $155
Current: $426.16
Upside: -63.63%
Sep 19, 2018
Maintains: Buy
Price Target: $85 → $90
Current: $121.65
Upside: -26.02%